◆英語タイトル:EyeGate Pharmaceuticals Inc (EYEG) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011685
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月13日
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
EyeGate Pharmaceuticals Inc (EyeGate) is a clinical-stage specialty pharmaceutical company that offers eye care medicines. The company offers macular edema and non-infectious anterior uveitis. It offers technologies for most prevalent issues in ophthalmic care; the existing lack of patient adherence and patient safety. EyeGate deliver drugs in optimal dosing regimens directly into the ocular tissue in both the anterior and posterior segments of the eye. The company offers EGP-437 that incorporates a reformulated corticosteroid, dexamethasone phosphate, which is delivered into the ocular tissues. It also offers drug delivery mechanisms for treating diseases of the eye. EyeGate is headquartered in Waltham, Massachusetts, the US.
EyeGate Pharmaceuticals Inc (EYEG) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
EyeGate Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
EyeGate Pharmaceuticals Inc, Medical Equipment, Deal Details 10
Venture Financing 10
EyeGate Pharma Raises USD2.6 Million in Venture Financing 10
EyeGate Pharma Raises US$1 Million In Venture Financing 11
EyeGate Pharma Secures An Additional US$5.9 Million In Series D Round Of Financing 12
Partnerships 13
Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 13
Avedro Enters Into Licensing Agreement With EyeGate Pharma For Iontophoresis Patents 15
Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 16
Equity Offering 17
EyeGate Pharma Raises USD10 Million in Public Offering of Shares and Warrants 17
EyeGate Pharmaceuticals Inc – Key Competitors 18
EyeGate Pharmaceuticals Inc – Key Employees 19
EyeGate Pharmaceuticals Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Aug 07, 2017: EyeGate Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business Update 21
May 08, 2017: EyeGate Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Business Update 23
Feb 23, 2017: EyeGate Pharmaceuticals Reports Full-year 2016 Financial Results and Provides Business Update 25
Nov 02, 2016: EyeGate Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Business Update 26
Aug 10, 2016: EyeGate Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business Update 27
May 13, 2016: Eyegate Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Business Update 29
Mar 29, 2016: EyeGate Reports Full-year 2015 Financial Results and Provides Business Update 31
Corporate Communications 32
Oct 23, 2017: Eye Care Thought Leaders Join EyeGate Scientific Advisory Board 32
Mar 13, 2017: EyeGate Pharmaceuticals appoints two new scientific advisory board members 33
Feb 06, 2017: EyeGate Pharmaceuticals Announces Executive Promotions 34
May 06, 2016: EyeGate Pharma Appoints Dr. Brenda K. Mann as Vice President, Research and Development 35
Apr 27, 2016: EyeGate Pharma Appoints Ryan R. Brenneman as Chief Financial Officer 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37
List of Tables
EyeGate Pharmaceuticals Inc, Medical Equipment, Key Facts, 2016 2
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
EyeGate Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
EyeGate Pharmaceuticals Inc, Deals By Market, 2011 to YTD 2017 8
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
EyeGate Pharma Raises USD2.6 Million in Venture Financing 10
EyeGate Pharma Raises US$1 Million In Venture Financing 11
EyeGate Pharma Secures An Additional US$5.9 Million In Series D Round Of Financing 12
Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 13
Avedro Enters Into Licensing Agreement With EyeGate Pharma For Iontophoresis Patents 15
Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 16
EyeGate Pharma Raises USD10 Million in Public Offering of Shares and Warrants 17
EyeGate Pharmaceuticals Inc, Key Competitors 18
EyeGate Pharmaceuticals Inc, Key Employees 19
EyeGate Pharmaceuticals Inc, Subsidiaries 20